Terms: = Thyroid cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
16 results:
1. Deep response to a combination of mtor inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.
Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N
Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
Wu M; Yuan H; Zou W; Xu S; Liu S; Gao Q; Guo Q; Han Y; An X
Clin Transl Oncol; 2024 Apr; 26(4):808-824. PubMed ID: 37864677
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive pan-cancer analysis of expression profiles and prognostic significance for NUMB and NUMBL in human tumors.
Zhang Y; Yang H; Liu W; Song Q; Li Y; Zhang J; Zhou D; Li A
Medicine (Baltimore); 2023 Sep; 102(35):e34717. PubMed ID: 37657045
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
6. The roles and mechanisms of circular RNAs related to mtor in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
7. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary thyroid Carcinoma by Activating PI3K/AKT/mtor Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract] [Full Text] [Related]
8. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract] [Full Text] [Related]
9. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
Lv C; Yang H; Yu J; Dai X
Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
[TBL] [Abstract] [Full Text] [Related]
10. Large contribution of copy number alterations in early stage of Papillary thyroid Carcinoma.
Hosseinkhan N; Honardoost M; Blighe K; Moore T; Khamseh ME
Comput Biol Med; 2021 Aug; 135():104584. PubMed ID: 34171638
[TBL] [Abstract] [Full Text] [Related]
11. Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.
Tilot AK; Frazier TW; Eng C
Neurotherapeutics; 2015 Jul; 12(3):609-19. PubMed ID: 25916396
[TBL] [Abstract] [Full Text] [Related]
12. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract] [Full Text] [Related]
13. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.
Onodera Y; Nam JM; Bissell MJ
J Clin Invest; 2014 Jan; 124(1):367-84. PubMed ID: 24316969
[TBL] [Abstract] [Full Text] [Related]
14. thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma.
Bianchi L; Rossi L; Tomao F; Papa A; Zoratto F; Tomao S
Endocr Relat Cancer; 2013 Oct; 20(5):R233-45. PubMed ID: 23833016
[TBL] [Abstract] [Full Text] [Related]
15. [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology].
Sardinoux M; Raingeard I; Bessis D; Coupier I; Renard E; Bringer J
Ann Endocrinol (Paris); 2010 Sep; 71(4):264-73. PubMed ID: 20627233
[TBL] [Abstract] [Full Text] [Related]
16. [Neuroendocrine carcinoma of the lung: a diagnostic and therapeutic challenge].
Böttger C; Warth A; Nawroth PP; Isermann B
Med Klin (Munich); 2010 Apr; 105(4):237-41. PubMed ID: 20455040
[TBL] [Abstract] [Full Text] [Related]
